britumomab (Zevalin)

From Aaushi
Jump to navigation Jump to search
[1][2]

Adverse effects

  • severe cutaneous or mucocutaneous reactions, some with fatal outcome

Mechanism of action

More general terms

References

  1. ↑ UniProt http://www.uniprot.org/uniprot/P11836.html
  2. ↑ Medwatch http://www.fda.gov/medwatch/safety/2005/safety05.htm#Zevalin
Retrieved from "https://aaushi.info/w/index.php?title=A25043&oldid=1172383"